Evidence map›Paper›PMID 34641481›Full record

ReviewMolecules (Basel, Switzerland)2021

Total Syntheses of Pladienolide-Derived Spliceosome Modulators.

Jaehoon Sim, Eunbin Jang, Hyun Jin Kim, Hongjun Jeon

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jaehoon SimCollege of Pharmacy, Chungnam National University, Daejeon 34134, Korea.ORCID 0000-0001-7981-9892
Eunbin JangCollege of Pharmacy, Chungnam National University, Daejeon 34134, Korea.ORCID 0000-0002-2046-5038
Hyun Jin KimTherapeutics and Biotechnology Division, Korea Research Institute of Chemical Technology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Korea.
Hongjun JeonTherapeutics and Biotechnology Division, Korea Research Institute of Chemical Technology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Korea.ORCID 0000-0001-5153-5118

Funding

Chungnam National University (2020-2021) Chungnam National University (2020-2021)Korea Research Institute of Chemical Technology BSF21-502 and KK2131-30
6 · The paper itself

Abstract

Pladienolides, an emerging class of naturally occurring spliceosome modulators, exhibit interesting structural features, such as highly substituted 12-membered macrocycles and epoxide-containing diene side chains. The potential of pladienolides as anti-cancer agents is confirmed by H3B-8800, a synthetic analog of this natural product class, which is currently under Phase I clinical trials. Since its isolation in 2004 and the first total synthesis in 2007, a dozen total syntheses and synthetic approaches toward the pladienolide class have been reported to date. This review focuses on the eight completed total syntheses of naturally occurring pladienolides or their synthetic analogs, in addition to a synthetic approach to the main framework of the natural product.

Indexed as

AnimalsAntineoplastic Agents, PhytogenicBiological ProductsEpoxy CompoundsHumansMacrolidesNeoplasmsSpliceosomesAntineoplastic Agents, PhytogenicBiological ProductsEpoxy CompoundsMacrolidespladienolide Bpladienolide Dmacrocyclesnatural productspladienolide classspliceosometotal synthesis

Identifiers

PMID34641481
PMCPMC8512135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.